Overall survival with immune checkpoint inhibitors across treatment settings and clinical and PD-L1-defined subgroups in advanced esophageal squamous cell carcinoma: a systematic review and meta-analysis of randomized trials - Bing Wang; Xiaoyu Han; Zengli Shen (Frontiers in Immunology, 2026)